UK Scientists Working on Ebola Vaccine Based on AstraZeneca Covid-19 Jab

An Ebola vaccine based on the same technology that delivered the AstraZeneca Covid-19 jab is being urgently developed by British scientists to help contain the deadly sub-strain enveloping the Democratic Republic of Congo (DRC) and its neighbors.

The Daily Telegraph reports the new vaccine is being developed by the Oxford Vaccine Group (OVG) using the platform deployed in 2020 as a baseline start.

The vax could be ready for clinical trials within two to three months, its makers say, then rushed into action once approved against the outbreak which has resulted in more than 204 suspected deaths and 870 suspected cases.

The manifestation in the DRC involves a rare species of Ebola called Bundibugyo, for which there is no vaccine. It is already one of the biggest outbreaks on record, with 750 suspected cases and 177 deaths.

Professor Teresa Lambe, Calleva head of vaccine immunology at the OVG, outlined the